Perspectives

• Medscape 2050: The Future of Medicine As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050.
  Medscape, January 01, 2025
• GLP-1 RAs: When Not to Prescribe   Dr Tamaan K. Osbourne-Roberts reviews the list of patients who probably should not be taking GLP-1 receptor agonists.
  Medscape Internal Medicine, December 31, 2024
• ASH 2024: Improving Care in Red Blood Cell Disorders   Dr Nadia Ali shares ASH 2024 highlights, including anticipated presentations, quick takeaways, and insights into the impact of new research in red blood cell disorders.
  Medscape, December 31, 2024
• Key Studies in Chronic Lymphocytic Leukemia From ASH 2024   Practice-changing studies in both frontline CLL and relapsed/refractory disease, presented at ASH 2024, are discussed by Dr Jennifer Woyach.
  Medscape, December 30, 2024
• Paroxysmal Nocturnal Hemoglobinuria Takeaways From ASH 2024   Symptom improvement with novel therapies and better patient-reported outcomes, as well as breakthrough hemolysis control, are among the paroxysmal nocturnal hemoglobinuria highlights from ASH 2024.
  Medscape, December 30, 2024
• Novel Insights in Thrombotic Disorders From ASH 2024   Rilzabrutinib and eltrombopag in immune thrombocytopenia, and the place of oral direct anticoagulation in venous thromboembolism, are among the novel insights in thrombotic disorders from ASH 2024.
  Medscape, December 30, 2024
• Shared Decision-Making in Systemic Lupus Erythematosus   Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. In this Care Cues, experts discuss strategies to promote shared decision-making with their SLE patients.
  Medscape, December 30, 2024
• DLBCL Highlights From ASH 2024   Dr John Leonard shares key updates on DLBCL at ASH 2024, including long-term POLARIX trial data, ctDNA insights, and real-world results for polatuzumab, liso-cel, and bispecifics after CAR-T failure.
  Medscape, December 30, 2024
• Chronic Myeloid Leukemia Highlights From ASH 2024   Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.
  Medscape, December 30, 2024
• Bottoms Down: Make Alcohol Screening a Clinical Priority Even those without chronic health conditions should be asked about alcohol intake. It’s the right thing to do.
  Medscape Family Medicine, December 27, 2024
• UK’s Assisted Dying Legislation: Balancing Pros and Cons   Prof David Kerr discusses a bill to support assisted dying in the United Kingdom.
  Medscape Oncology, December 27, 2024
• ASH 2024: Impact of New CML Treatments   Dr Lindsay Rein highlights how new CML data bring important considerations for clinical practice, patient tolerance, and the impact of treatment costs on quality of life.
  Medscape, December 27, 2024
• Progression on Systemic Therapy: Additional Considerations   Dr Mark Kris continues a discussion about considerations related to the many faces of progression on systemic therapy.
  Medscape Oncology, December 26, 2024
• ASH 2024: The Clinical Impact of New CLL Data   Dr Suchitra Sundaram reflects on how ASH updates will address her patients' questions about the value of MRD testing in CLL treatment.
  Medscape, December 26, 2024
• Is Supplemental Oxygen Worth the Cost? Oxygen therapy saves lives, but does it improve quality of life? Dr Holley explores the balance of benefits, burdens, and cost in modern oxygen prescribing.
  Medscape Critical Care, December 24, 2024
• Make Networking a Priority for Med School Success   Dr JR Smith discusses the importance of networking for medical school success.
  Medscape, December 24, 2024
• Preventing DKA in Patients With T1D on SGLT2 Inhibitors   Dr Anne Peters discusses how to safely prescribe SGLT2 inhibitors in patients with type 1 diabetes to prevent diabetic ketoacidosis.
  Medscape Diabetes & Endocrinology, December 23, 2024
• Disrupting the Status Quo: We Need More Pragmatic Trials   Dr Maurie Markman discusses the need for pragmatic trials to help patients with advanced cancer.
  Medscape Oncology, December 23, 2024
• The Year in Gastroenterology: 10 Must-Read Studies In a year of pivotal gastroenterology research, these 10 articles were in a class of their own, according to Dr David Johnson.
  Medscape Gastroenterology, December 23, 2024
• New Directions in Anemia and Related Disorders From ASH 2024   Strategies to reduce disease burden in alpha- or beta-thalassemia, sickle cell disease, and polycythemia vera, and insights into anemia in IBD, are among anemia highlights from ASH 2024.
  Medscape, December 23, 2024